Changes in epidemiologic features of testicular germ cell cancer: Age at diagnosis and relative frequency of seminoma are constantly and significantly increasing

Urologic Oncology: Seminars and Original Investigations

Volumn 32, Issue 1, 2014, Pages 33.e1-33.e6

  Ruf, Christian G ^a,b   Isbarn, Hendrik ^b   Wagner, Walter ^a   Fisch, Margit ^b   Matthies, Cord ^a   Dieckmann, Klaus Peter ^c  

^a Bundeswehrkrankenhaus Hamburg   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c ALBERTINEN KRANKENHAUS   (Germany)

Author keywords

Age at diagnosis; Epidemiology; Nonseminoma; Seminoma; Testicular germ cell tumor

Indexed keywords

ADOLESCENT; ADULT; AGE AT DIAGNOSIS; AGED; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; GERM CELL TUMOR; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON SEMINOMATOUS GERMINOMA; PRIMARY TUMOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEMINOMA; TREND STUDY; VERY ELDERLY; YOUNG ADULT; AGE; NEOPLASMS, GERM CELL AND EMBRYONAL; ONSET AGE; TESTICULAR NEOPLASMS;

ADOLESCENT; ADULT; AGE FACTORS; AGE OF ONSET; AGED; AGED, 80 AND OVER; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, GERM CELL AND EMBRYONAL; RETROSPECTIVE STUDIES; SEMINOMA; TESTICULAR NEOPLASMS; YOUNG ADULT;

EID: 84890797471     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2012.12.002     Document Type: Article

References (30)

1. Rosen A., Jayram G., Drazer M., Eggener S.E. Global trends in testicular cancer incidence and mortality. Eur Urol 2011, 60(2):374-379.
2. Bray F., Ferlay J., Devesa S.S., McGlynn K.A., Moller H. Interpreting the international trends in testicular seminoma and nonseminoma incidence. Nat Clin Pract Urol 2006, 3:532-543.
3. Bray F., Richiardi L., Ekbom A., Pukkala E., Cuninkova M., Moller H. Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality. Int J Cancer 2006, 118:3099-3111.
4. Dieckmann K.P., Skakkebaek N.E. Carcinoma in situ of the testis: a review of biological and clinical features. Int J Cancer 1999, 83:815-822.
5. Germa-Lluch J.R., Garcia del Muro X., Maroto P., Paz-Ares L., Arranz J.A., Guma J., et al. Clinical pattern and therapeutic esults achieved in 1490 patients with germ-cell tumours of the testis: the experience of the Spanish Germ-Cell Cancer Group (GG). Eur Urol 2002, 42:553-563.
6. Dixon F.J., Moore R.A. Testicular tumors. A clinicopathologic study. Cancer 1953, 6:427-454.
7. MacKay E.N., Sellers A.H. A statistical study of malignant testicular tumours based on the experience of the Ontario cancer Foundation Clinics, 1938-1961. Canad Med Ass J 1966, 94:889-899.
8. Krag Jacobsen G., Barlebo H., Olsen J., Schultz H.P., Starklint H., Sögaaard H., et al. Testicular germ cell tumours in Denmark 1976-1980. Acta Radiol Oncol 1984, 23(4):239-247.
9. Stiller D., Katenkamp D., Pressler H., Kosmehl H. [Germ cell tumors of testis: histological classification of 552 cases according to the WHO-nomenclature]. Zentralbl Allg Pathol 1983, 128:85-100. [in German].
10. Stiens R. Testikuläre Keimzelltumoren: Histologie, Klassifikation, Pathologie und Häufigkeit. Register und Verbundstudie für Hodentumoren - Bonn Ergebnisse einer prospektiven Untersuchung 1982, 27-50. W. Zuckschwerdt Verlag, Munich. L. Weißbach, G. Hildenbrand (Eds.).
11. Petersen G.R., Lee J.A. Secular trends of malignant tumors of the testis in white men. J Natl Cancer Inst 1972, 49:339-354.
12. Weir H.K., Marrett L.D., Moravan V. Trends in the incidence of testicular germ cell cancer in Ontario by histologic subgroup 1964-1996. Can Med Ass J 1999, 160(2):201-205.
13. Pharris-Ciurej N.D., Cook L.S., Weiss N.S. Incidence of testicular cancer in the United States: has the epidemic begun to abate?. Am J Epidemiol 1999, 150:45-46.
14. Krebs in Deutschland 2007/2008 2012, Robert Koch Institut & Gesellschaft der epidemiologischen Krebsregister in Deutschland, Robert Koch Institut, Berlin. 8th ed.
15. Levi F., Te V.C., La Vecchia C. Testicular cancer trends in the Canton of Vaud, Switzerland, 1974-1987. Br J Cancer 1990, 62:871-873.
16. Kohout Stage I seminoma: trends in utilization of adjuvant therapy following orchiectomy using the national cancer database. J Urol 2012, (Suppl.). [Abstract 661].
17. Sokoloff M.H., Joyce G.F., Wise M. Urologic diseases in America project: testis cancer. J Urol 2007, 177:2030-2041.
18. Speaks C., McGlynn K.A., Cook M.B. Significant calendar period deviations in testicular germ cell tumors indicate that postnatal exposures are etiologically relevant. Cancer Causes Control 2012, 23(10):1593-1598.
19. McKiernan J.M., Goluboff E.T., Liberson G.L., Golden R., Fisch H. Rising risk of testicular cancer by birth cohort in the United States from 1973 to 1995. J Urol 1999, 162:361-363.
20. Powles T.B., Bhardwa J., Shamash J., Mandalia S., Oliver T. The changing presentation of germ cell tumours of the testis between 1983 and 2002. BJU Int 2005, 95:1197-1200.
21. Stang A., Kuss O. Etiologic differences between seminoma and nonseminoma of the testis: a systematic review of epidemiologic studies. Hematol Oncol Clin North Am 2011, 25(3):473-486.
22. Aschim E.L., Haugen T.B., Tretli S., Daltveit A.K., Grotmol T. Risk factors for testicular cancer-differences between pure non-seminoma and mixed seminoma/non-seminoma?. Int J Androl 2006, 29:458-467.
23. Coupland C.A., Chilvers C.E., Davey G., Pike M.C., Oliver R.T., Forman D. Risk factors for testicular germ cell tumours by histological tumour type. United Kingdom Testicular Cancer Study Group. Br J Cancer 1999, 80:1859-1863.
24. Dieckmann K.P., Hartmann J.T., Classen J., Diederichs M., Pichlmeier U. Is increased body mass index associated with the incidence of testicular germ cell cancer?. J Cancer Res Clin Oncol 2009, 135:731-738.
25. Meeks J.J., Sheinfeld J., Eggener S.E. Environmental toxicology of testicular cancer. Urol Oncol 2012, 30(2):212-215.
26. Stone J.M., Sandeman T.F., Ironside P., Cruickshank D.G., Matthews J.P. Time trends in accuracy of classification of testicular tumours, with clinical and epidemiological implications. Br J Cancer 1992, 66:396-401.
27. Moller H. Clues to the aetiology of testicular germ cell tumours from descriptive epidemiology. Eur Urol 1993, 23(1):8-13.
28. Stone J.M., Cruickshank D.G., Sandeman T.F., Matthews J.P. Trebling of the incidence of testicular cancer in Victoria, Australia (1950-1985). Cancer 1991, 68(1):211-219.
29. Richiardi L., Bellocco R., Adami H.O., Torrang A., Barlow L., Hakulinen T., et al. Testicular cancer incidence in eight northern European countries: secular and recent trends. Cancer Epidemiol Biomarkers Prev 2004, 13:2157-2166.
30. Heinzelbecker J., Katzmarzik M., Weiss C., Trojan L., Michel M.S., Haecker A. Changes of stage, predictive factors and adjuvant treatment modalities in seminomatous testicular cancer from 1987 to 2007 and their impact on the status of metastasis, recurrence-free and overall survival: a single-center analysis. Urol Int 2011, 87(3):282-287.